Technology M&A Advisory

M&A Advisory

Lazard

Full Credential Description

Immunomedics. United States. Announced Date 10/05/2006. Closed Date 10/05/2006. Immunomedics and UCB announce worldwide development collaboration and license agreement for Epratuzumab. Industry: Immunomedics is a biotechnology company focused on developing antibody-drug conjugates for the treatment of cancer.

Back to Search Contact Business